Fennec Cash from 2010 to 2026

FENC Stock  USD 8.20  0.38  4.86%   
Fennec Pharmaceuticals' Cash is increasing over the years with slightly volatile fluctuation. Overall, Cash is expected to go to about 32.2 M this year. Cash is the total amount of money in the form of currency that Fennec Pharmaceuticals has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2000-06-30
Previous Quarter
18.7 M
Current Value
21.9 M
Quarterly Volatility
10.9 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Fennec Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fennec Pharmaceuticals' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 874 K or Interest Expense of 4.9 M, as well as many indicators such as Price To Sales Ratio of 3.96, Dividend Yield of 0.0 or Days Sales Outstanding of 108. Fennec financial statements analysis is a perfect complement when working with Fennec Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Fennec Stock
Check out the analysis of Fennec Pharmaceuticals Correlation against competitors.
For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.
Analyzing Fennec Pharmaceuticals's Cash over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Cash has evolved provides context for assessing Fennec Pharmaceuticals's current valuation and future prospects.

Latest Fennec Pharmaceuticals' Cash Growth Pattern

Below is the plot of the Cash of Fennec Pharmaceuticals over the last few years. Cash refers to the most liquid asset of Fennec Pharmaceuticals, which is listed under current asset account on Fennec Pharmaceuticals balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Fennec Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Fennec Pharmaceuticals account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Fennec Pharmaceuticals' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fennec Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Fennec Cash Regression Statistics

Arithmetic Mean15,244,163
Geometric Mean7,577,672
Coefficient Of Variation80.35
Mean Deviation11,026,982
Median13,650,000
Standard Deviation12,247,962
Sample Variance150T
Range32M
R-Value0.83
Mean Square Error49.5T
R-Squared0.69
Significance0.000036
Slope2,015,452
Total Sum of Squares2400.2T

Fennec Cash History

202632.2 M
202530.6 M
202426.6 M
202313.3 M
202223.8 M
202121.1 M
202030.3 M

Other Fundumenentals of Fennec Pharmaceuticals

Fennec Pharmaceuticals Cash component correlations

About Fennec Pharmaceuticals Financial Statements

Fennec Pharmaceuticals stakeholders use historical fundamental indicators, such as Fennec Pharmaceuticals' Cash, to determine how well the company is positioned to perform in the future. Although Fennec Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Fennec Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Fennec Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Fennec Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash30.6 M32.2 M
Cash And Short Term Investments30.6 M32.2 M
Change In Cash15.4 M16.1 M
Free Cash Flow31 M32.6 M
Begin Period Cash Flow15.3 M10.8 M
Other Cashflows From Financing Activities-395.1 K-375.3 K
Other Non Cash Items33 M34.7 M
Total Cash From Operating Activities31 M32.6 M
Total Cash From Financing Activities-12.3 M-11.6 M
End Period Cash Flow30.6 M32.2 M
Cash And Cash Equivalents Changes-8.3 M-7.9 M
Cash Flows Other Operating-192.6 K-183 K
Free Cash Flow Yield 0.14  0.15 
Operating Cash Flow Per Share 0.89  0.93 
Free Cash Flow Per Share 0.89  0.93 
Cash Per Share 1.12  1.07 
EV To Operating Cash Flow 7.04  7.39 
EV To Free Cash Flow 7.04  7.39 
Price To Operating Cash Flows Ratio 7.35  7.72 
Price To Free Cash Flows Ratio 7.35  7.72 
Cash Ratio 3.46  4.42 
Cash Conversion Cycle(173.76)(165.07)
Operating Cash Flow Sales Ratio 0.51  0.54 
Free Cash Flow Operating Cash Flow Ratio 1.15  1.13 
Cash Flow Coverage Ratios 1.26  1.32 
Price Cash Flow Ratio 7.35  7.72 
Cash Flow To Debt Ratio 1.26  1.32 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:
Check out the analysis of Fennec Pharmaceuticals Correlation against competitors.
For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Will Biotechnology sector continue expanding? Could Fennec diversify its offerings? Factors like these will boost the valuation of Fennec Pharmaceuticals. Market participants price Fennec higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fennec Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.26)
Revenue Per Share
1.408
Quarterly Revenue Growth
0.787
Return On Assets
(0.05)
Return On Equity
(10.06)
Understanding Fennec Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Fennec's accounting equity. The concept of intrinsic value - what Fennec Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Fennec Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Fennec Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.